![Amy Sullivan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Amy Sullivan
No open positions remaining
Net worth: 516 $ as of 29/06/2026
Profile
Ms. Amy B. Sullivan was previously employed as a Chief Financial & Accounting Officer by IO Biotech, Inc., a Chief Strategy Officer by Kiadis Pharma NV, a Senior Vice President-Corporate Affairs by Keryx Biopharmaceuticals, Inc., a VP-Corporate Communications & Investor Relations by AMAG Pharmaceuticals, Inc., a Head-Corporate Communications & Investor Relations by Genencor International, Inc., and a Head-Corporate Communications & Investor Relations by Idenix Pharmaceuticals LLC.
She received her undergraduate degree from Salem International University and an MBA from Bentley University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IO BIOTECH, INC. 0.12% | 10/04/2025 | 84,632 ( 0.12% ) | 516 $ | 29/06/2026 |
Former positions of Amy Sullivan
| Companies | Position | End |
|---|---|---|
| IO BIOTECH, INC. | Director of Finance/CFO | 30/03/2026 |
| KERYX BIOPHARMACEUTICALS | Public Communications Contact | - |
Genencor International, Inc.
 Genencor International, Inc. BiotechnologyHealth Technology Develops and manufactures enzyme product solutions | Investor Relations Contact | - |
| IDENIX PHARMACEUTICALS INC | Investor Relations Contact | - |
| KIADIS PHARMA N.V. | Investor Relations Contact | - |
Training of Amy Sullivan
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
48
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Genencor International, Inc.
Genencor International, Inc. BiotechnologyHealth Technology Develops and manufactures enzyme product solutions | Health Technology |
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and infectious diseases caused by hepatitis | Health Technology |
Bentley University
 Bentley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Salem International University
 Salem International University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Kiadis Pharma NV
 Kiadis Pharma NV Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company focused on research, development and commercialization of cell based immunotherapy products | Health Technology |
IO Biotech, Inc.
 IO Biotech, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel, immune-modulating cancer therapies | Health Technology |
- Stock Market
- Insiders
- Amy Sullivan
